MYGN Stock Analysis: Buy, Sell, or Hold?
MYGN - Myriad Genetics Inc
$3.69
0.10 (2.93%)
▲
5d:
-12.47%
30d:
-27.46%
90d:
-18.11%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Smart Money Accumulation
MYGN is down 16.6% this week, but smart money is accumulating calls. Top strike: $4 2026-06-18 with 74 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When MYGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called MYGN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MYGN is down 12.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MYGN is down 12.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MYGN is currently trading at $3.69, which is considered oversold relative to its 30-day fair value range of $4.07 to $5.05. From a valuation perspective, the stock is trading at a discount (Forward PE: 21.6) compared to its historical average (58.8). Remarkably, the market is currently pricing in an annual earnings decline of 28.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, MYGN is in a strong downtrend. Immediate support is located at $3.56, while resistance sits at $5.04.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.28 (+75.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MYGN is in a strong downtrend. Immediate support is located at $3.56, while resistance sits at $5.04.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.28 (+75.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.07 -
$5.05
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding MYGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 75.4% below Wall St target ($6.28)
- WARNING: Recommendation downgraded due to -12.5% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$4.07 -
$5.05
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.56
Resistance Level
$5.04
Current Trend
Strong Downtrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.57
Wall Street Target
$6.28
(+75.4%)
Revenue Growth (YoY)
-20.8%
Profit Margin
-41.3%
Valuation Discount vs History
-28.4% cheaper
PE vs Historical
21.6 vs 58.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-28.4%
(market-implied from PE analysis)
1-Year Target
$3.22
(-10%)
2-Year Target
$2.90
(-19%)
3-Year Target
$2.61
(-27%)
3-Yr Target (if PE normalizes)
(PE: 22→59)
$7.12
(+99%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 232.0%)
$12.36
(+245%)
Base:
(SPY PE: 21.6, Growth: 232.0%)
$12.08
(+238%)
Bear:
(PE: 18.3, Growth: 232.0%)
$10.27
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 21.6 to 58.8
Stabilization Target:
$9.76
(+172.6%)
PE Expansion Potential:
+172.6%
Share & Embed Analysis
Last updated: May 18, 2026 12:08 PM ET
Data refreshes hourly during market hours. Next update: 1:08 PM
Data refreshes hourly during market hours. Next update: 1:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MYGN showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Samraat S Raha
BUY
40000 shares
2026-03-09
S. Louise Phanstiel
BUY
48000 shares
2026-02-27
S. Louise Phanstiel
BUY
50407 shares
2026-02-26
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$613 | 54 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$248 | 53 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$131 | 60 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 49 HOLD |
Advanced MYGN Option Strategies
Professional options setups generated by AI based on today's MYGN price and gamma walls.
